Fred Alger Management, LLC Tandem Diabetes Care Inc Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

A detailed history of Fred Alger Management, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 1,979,119 shares of TNDM stock, worth $59.7 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

1,979,119

Previous 2,174,107 8.97%

Holding current value

$59.7 Million

Previous $87.6 Million 4.2%

% of portfolio

0.42%

Previous 0.44%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$35.21 - $47.3 $6.87 Million - $9.22 Million	-194,988 Reduced 8.97%	1,979,119 $83.9 Million
Q2 2024 Aug 14, 2024	BUY	$30.43 - $53.43 $20.6 Million - $36.2 Million	677,036 Added 45.22%	2,174,107 $87.6 Million
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $26.4 Million - $42.3 Million	1,194,292 Added 394.44%	1,497,071 $53 Million
Q4 2023 Feb 14, 2024	SELL	$14.28 - $31.03 $327,154 - $710,897	-22,910 Reduced 7.03%	302,779 $8.96 Million
Q3 2023 Nov 14, 2023	BUY	$19.33 - $36.22 $2.13 Million - $3.99 Million	110,049 Added 51.03%	325,689 $6.76 Million
Q2 2023 Aug 14, 2023	SELL	$24.18 - $42.46 $212,010 - $372,289	-8,768 Reduced 3.91%	215,640 $5.29 Million
Q1 2023 May 15, 2023	BUY	$35.86 - $46.5 $2.84 Million - $3.68 Million	79,241 Added 54.59%	224,408 $9.11 Million
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $1.22 Million - $1.94 Million	-34,506 Reduced 19.2%	145,167 $6.53 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $1.51 Million - $2.39 Million	34,583 Added 23.84%	179,673 $8.6 Million
Q2 2022 Aug 15, 2022	SELL	$53.22 - $123.09 $187,440 - $433,522	-3,522 Reduced 2.37%	145,090 $8.59 Million
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $74,175 - $109,265	-728 Reduced 0.49%	148,612 $17.3 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $578,372 - $749,809	-4,894 Reduced 3.17%	149,340 $22.5 Million
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $1.74 Million - $2.41 Million	-18,658 Reduced 10.79%	154,234 $18.4 Million
Q2 2021 Aug 16, 2021	SELL	$77.0 - $100.19 $161,084 - $209,597	-2,092 Reduced 1.2%	172,892 $16.8 Million
Q1 2021 May 17, 2021	SELL	$81.28 - $104.34 $93.6 Million - $120 Million	-1,150,967 Reduced 86.8%	174,984 $15.4 Million
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $5.45 Million - $7.68 Million	-63,116 Reduced 4.54%	1,325,951 $127 Million
Q3 2020 Nov 13, 2020	BUY	$95.43 - $116.09 $9.09 Million - $11.1 Million	95,286 Added 7.36%	1,389,067 $158 Million
Q2 2020 Aug 14, 2020	BUY	$60.05 - $98.92 $21.5 Million - $35.4 Million	357,570 Added 38.19%	1,293,781 $128 Million
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $23.6 Million - $44.9 Million	-498,795 Reduced 34.76%	936,211 $60.2 Million
Q4 2019 Feb 14, 2020	SELL	$53.13 - $71.19 $28 Million - $37.5 Million	-526,697 Reduced 26.85%	1,435,006 $85.5 Million
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $12.3 Million - $15.8 Million	-215,252 Reduced 9.89%	1,961,703 $116 Million
Q2 2019 Aug 14, 2019	SELL	$54.41 - $71.7 $25.3 Million - $33.3 Million	-464,927 Reduced 17.6%	2,176,955 $140 Million
Q1 2019 May 14, 2019	SELL	$32.25 - $73.56 $17.5 Million - $39.9 Million	-542,198 Reduced 17.03%	2,641,882 $168 Million
Q4 2018 Feb 14, 2019	SELL	$28.45 - $40.65 $5.33 Million - $7.61 Million	-187,292 Reduced 5.56%	3,184,080 $121 Million
Q3 2018 Nov 14, 2018	BUY	$21.39 - $51.17 $30 Million - $71.7 Million	1,401,188 Added 71.12%	3,371,372 $144 Million
Q2 2018 Jul 19, 2018	BUY	$4.9 - $23.64 $9.56 Million - $46.1 Million	1,950,184 Added 9750.92%	1,970,184 $43.4 Million
Q1 2018 May 10, 2018	BUY	$2.35 - $4.96 $47,000 - $99,200	20,000 New	20,000 $99,000

Others Institutions Holding TNDM

# of Institutions

360

Shares Held

72.5M

Call Options Held

3.36M

Put Options Held

229K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.94B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Tandem Diabetes Care Inc Transaction History